FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dennis Revicki

Research Profile

Concepts & Ideas

Activities & Behaviors

Procedures

Geographic Areas

United States

Chemicals & Drugs

Antipsychotic Agents

Disorders

Co-author Network

Publications

TOP 3
Jiseon Kim; Dennis A Revicki; Dagmar Amtmann; Hyewon Chung; Karon F Cook
Measurement invariance of the PROMIS pain interference item bank across community and clinical samples.
Dennis A Revicki; Ren Yu; Nancy A Brandenburg; Robert Knight; Petra Muus; Pierre Fenaux
Health-related quality of life outcomes of lenalidomide in transfusion-dependent patients with Low- or Intermediate-1-risk myelodysplastic syndromes with a chromosome 5q deletion: results from a randomized clinical trial.
Louis S Matza; Lindsey T Murray; Glenn A Phillips; Karen Malley; Kathleen W Wyrwich; Dennis A Revicki
The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dennis Revicki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jiseon Kim; Dennis A Revicki; Dagmar Amtmann; Hyewon Chung; Karon F Cook
Measurement invariance of the PROMIS pain interference item bank across community and clinical samples.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2013;22(3):501-7.
2013: Dennis A Revicki; Ren Yu; Nancy A Brandenburg; Robert Knight; Petra Muus; Pierre Fenaux
Health-related quality of life outcomes of lenalidomide in transfusion-dependent patients with Low- or Intermediate-1-risk myelodysplastic syndromes with a chromosome 5q deletion: results from a randomized clinical trial.
Leukemia research 2013;37(3):259-65.
2013: Louis S Matza; Lindsey T Murray; Glenn A Phillips; Karen Malley; Kathleen W Wyrwich; Dennis A Revicki
The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2013;22(2):351-60.
2013: Melanie Calvert; David Moher; Dennis A Revicki; Douglas G Altman; Jane Blazeby; Michael D Brundage
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.
JAMA : the journal of the American Medical Association 2013;309(8):814-22.
2013: Rupali K Naik; Anne M Rentz; Scott M Whitcup; Rubens Belfort; C Stephen Foster; Jonathan W Kowalski; Susan Lightman; Careen Lowder; Dennis A Revicki
Normative comparison of patient-reported outcomes in patients with noninfectious uveitis.
JAMA ophthalmology 2013;131(2):219-25.
2013: Shima Safikhani; Murali Sundaram; Yanjun Bao; Parvez Mulani; Dennis A Revicki
Qualitative assessment of the content validity of the Dermatology Life Quality Index in patients with moderate to severe psoriasis.
The Journal of dermatological treatment 2013;24(1):50-9.
2013: Pranav K Gandhi; Darren DeWalt; Kelly M Kenzik; Dennis A Revicki; Elizabeth A Shenkman; Lindsay A Thompson; I-Chan Huang
Exploring factors influencing asthma control and asthma-specific health-related quality of life among children.
Respiratory research 2013;14():26.
2012: Louis S Matza; Haya Ascher-Svanum; Douglas E Faries; A George Awad; Richard S E Keefe; Bruce J Kinon; Karen Malley; Andrew C Palsgrove; Glenn A Phillips; Dennis A Revicki; Virginia L Stauffer; Dieter Naber
Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia.
Psychiatry research 2012;200(2-3):835-42.
2012: PEGGY ORR; Anne M Rentz; Dennis A Revicki; Shoshana Colman; Chantal M Dolan; Jennifer T Fine; Mary Kay Margolis; Neil M Bressler
Author response: Validation of the National Eye Institute Visual Function Questionnaire-25 (NEIVFQ-25) in age-related macular degeneration.
Investigative ophthalmology & visual science 2012;53(13):7950.
2012: Sara Ahmed; Ethan Basch; Richard A Berzon; William R Lenderking; Carol M Moinpour; Bryce B Reeve; Dennis A Revicki; Albert W Wu
The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.
Medical care 2012;50(12):1060-70.
2012: Christian Bime; Janet T Holbrook; Dennis A Revicki; Marianna M Sockrider; Christine Y Wei; Robert Wise
Asthma symptom utility index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients.
The Journal of allergy and clinical immunology 2012;130(5):1078-84.
2012: Dennis A Revicki; David V Sheehan; Henrik Svedsäter; Karin Travers; Kathleen W Wyrwich; Julie Locklear; Maria Stoeckl Mattera; Stuart Montgomery
Humanistic and economic burden of generalized anxiety disorder in North America and Europe.
Journal of affective disorders 2012;140(2):103-12.
2012: I-Chan Huang; Kevin Krull; Zhushan Li; Gwendolyn P Quinn; Dennis A Revicki; Elizabeth Shenkman; Pey-Shan Wen; Patricia Shearer
Using three legacy measures to develop a health-related quality of life tool for young adult survivors of childhood cancer.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012;21(8):1437-50.
2012: Leah Kleinman; Maria Stoeckl Mattera; Katy Benjamin; Douglas W Blayney; Linda Bosserman; Hema Viswanathan; Dennis A Revicki
The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012;21(7):1255-66.
2012: Thomas A Eaton; Sandra D Comer; Dennis A Revicki; JOSEPH STAUFFER; Jeremiah J Trudeau; Richard G van Inwegen; Nathaniel P Katz
Determining the clinically important difference in visual analog scale scores in abuse liability studies evaluating novel opioid formulations.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012;21(6):975-81.
2012: Kirsten L Johansen; Dennis A Revicki; Shaowei Wan; Christopher P Evans; Fredric O Finkelstein; Matthew Gitlin; Irene L Agodoa
Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(6):2418-25.
2012: Dennis A Revicki; Raymond C Rosen; William Fisher; Vladimir Hanes; Miriam Kuppermann; Mary Kay Margolis; Michael Sand
Evaluation of the Sexual Desire Relationship Distress Scale (SDRDS) in women with hypoactive sexual desire disorder.
The journal of sexual medicine 2012;9(5):1344-54.
2012: Carolyn E Schwartz; Dennis A Revicki
Mixing methods and blending paradigms: some considerations for future research.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012;21(3):375-6.
2012: Jonathan W Kowalski; Jeff Lee; Paul Lee; Andrew Lloyd; Anne M Rentz; John E Brazier; Neil M Bressler; Wen-Hung Chen; Ron D Hays; John G Walt; Tracey A Young; Dennis A Revicki
Rasch analysis in the development of a simplified version of the National Eye Institute Visual-Function Questionnaire-25 for utility estimation.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012;21(2):323-34.
2012: Dennis A Revicki; Donald Stull; Dianne Tomita; Margaret Vernon; Michael Rader; Hema N Viswanathan
Assessing the effect of darbepoetin alfa on patient-reported fatigue in chemotherapy-induced anemia in four randomized, placebo-controlled clinical trials.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012;21(2):311-21.
2012: Dennis A Revicki; William R Lenderking
Methods and issues associated with the use of quality-adjusted life-years.
Expert review of pharmacoeconomics & outcomes research 2012;12(1):105-14.
2012: Sherilyn M Notte; Isaac Odeyemi; Wen-Hung Chen; Zalmai Hakimi; Misun Lee; Thomas S Marshall; Dennis A Revicki
Content validity and test-retest reliability of Patient Perception of Intensity of Urgency Scale (PPIUS) for overactive bladder.
BMC urology 2012;12():26.
2012: Louis S Matza; Haya Ascher-Svanum; A George Awad; Douglas E Faries; Richard Se Keefe; Bruce J Kinon; Karen Malley; Andrew C Palsgrove; Glenn A Phillips; Dennis A Revicki; Virginia L Stauffer; Dieter Naber
Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation.
Patient preference and adherence 2012;6():521-32.
2012: Dennis A Revicki; Shima Safikhani; Alfons J M van den Eertwegh; Samuel Wagner; Celeste Lebbe; Gerald Linette; Paul Lorigan; Marianne Messina; Christian H Ottensmeier; Axel Hoos; Srividya Kotapati
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment.
Health and quality of life outcomes 2012;10():66.
2012: Michael H Allen; Larry Alphs; John J Bartko; Carla M Canuso; David G Daniel; Dong-Jing Fu; K Jack Ishak; Dennis A Revicki; Ibrahim Turkoz; Jean-Pierre Lindenmayer
Development and psychometric evaluation of a clinical global impression for schizoaffective disorder scale.
Innovations in clinical neuroscience 2012;9(1):15-24.
2011: Robin Pokrzywinski; Larry E Puls; Angeles Alvarez Secord; Laura Havrilesky; Robert V Higgins; Robert W Holloway; Matthew F Kohler; George S Lewandowski; Lawrence R Nycum; Dennis A Revicki
Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial.
Gynecologic oncology 2011;123(3):505-10.
2011: Louis S Matza; Lindsey Murray; Glenn A Phillips; Dennis A Revicki; Karen Malley
Development and validation of a patient-report measure of fatigue associated with depression.
Journal of affective disorders 2011;134(1-3):294-303.
2011: Louis S Matza; Glenn A Phillips; Dennis A Revicki; Jodi M Shorr; Virginia L Stauffer; Haya Ascher-Svanum; Dawn Kaiser; Bruce J Kinon
Development of a clinician questionnaire and patient interview to assess reasons for antipsychotic discontinuation.
Psychiatry research 2011;189(3):463-8.
2011: I-Chan Huang; Walter L Leite; Dennis A Revicki; Michael Seid; Patricia Shearer; Elizabeth Shenkman
Differential item functioning in quality of life measure between children with and without special health-care needs.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2011;14(6):872-83.
2011: Dennis A Revicki; Mary K Margolis; Elizabeth N Bush; Leonard R DeRogatis; Vladimir Hanes
Content validity of the Female Sexual Function Index (FSFI) in pre- and postmenopausal women with hypoactive sexual desire disorder.
The journal of sexual medicine 2011;8(8):2237-45.
2011: Dennis A Revicki; David W Sandor; Mary Kay Margolis; Eli O Meltzer; Christine L Thompson; James W Shaw
Major symptom score utility index for patients with acute rhinosinusitis.
American journal of rhinology & allergy 2011;25(3):99-106.
2011: Leah Kleinman; Suzanne Nelson; Smita Kothari-Talwar; Laurie Roberts; Susan R Orenstein; Reema R Mody; Eric Hassall; Ben Gold; Dennis A Revicki; Omar Dabbous
Development and psychometric evaluation of 2 age-stratified versions of the Pediatric GERD Symptom and Quality of Life Questionnaire.
Journal of pediatric gastroenterology and nutrition 2011;52(5):514-22.
2011: PEGGY ORR; Anne M Rentz; Mary Kay Margolis; Dennis A Revicki; Chantal M Dolan; Shoshana Colman; Jennifer T Fine; Neil M Bressler
Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration.
Investigative ophthalmology & visual science 2011;52(6):3354-9.
2011: Kathleen W Wyrwich; Neesha Harnam; Dennis A Revicki; Julie C Locklear; Henrik Svedsater; Jean Endicott
Assessment of quality of life enjoyment and satisfaction questionnaire-short form responder thresholds in generalized anxiety disorder and bipolar disorder studies.
International clinical psychopharmacology 2011;26(3):121-9.
2011: Kathleen W Wyrwich; Neesha Harnam; Julie C Locklear; Henrik Svedsäter; Dennis A Revicki
Understanding the relationships between health outcomes in generalized anxiety disorder clinical trials.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2011;20(2):255-62.
2011: Dennis A Revicki; Michelle P Luo; Anne M Rentz; Robert L Wong
Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis.
Health and quality of life outcomes 2011;9():36.
2011: Katherine Gooch; David Feeny; Robert L Wong; Hartmut Kupper; Aileen L Pangan; Dennis A Revicki; Désirée van der Heijde
Is the Health Utilities Index 3 valid for patients with ankylosing spondylitis?
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2011;14(1):160-5.
2010: Roger E Meyer; Carl Salzman; Eric A Youngstrom; Paula J Clayton; Frederick K Goodwin; J John Mann; Larry D Alphs; Karl Broich; Wayne K Goodman; John F Greden; Herbert Y Meltzer; Sharon-Lise T Normand; Kelly Posner; David Shaffer; Maria A Oquendo; Barbara Stanley; Madhukar H Trivedi; Gustavo Turecki; Charles M Beasley; Annette L Beautrais; Jeffrey A Bridge; Gregory K Brown; Dennis A Revicki; Neal D Ryan; David V Sheehan
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement.
The Journal of clinical psychiatry 2010;71(8):e1-e21.
2010: Roger E Meyer; Carl Salzman; Eric A Youngstrom; Paula J Clayton; Frederick K Goodwin; J John Mann; Larry D Alphs; Karl Broich; Wayne K Goodman; John F Greden; Herbert Y Meltzer; Sharon-Lise T Normand; Kelly Posner; David Shaffer; Maria A Oquendo; Barbara Stanley; Madhukar H Trivedi; Gustavo Turecki; Charles M Beasley; Annette L Beautrais; Jeffrey A Bridge; Gregory K Brown; Dennis A Revicki; Neal D Ryan; David V Sheehan
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report.
The Journal of clinical psychiatry 2010;71(8):1040-6.
2010: Kathleen W Wyrwich; Reema Mody; Lois M Larsen; Misun Lee; Neesha Harnam; Dennis A Revicki
Validation of the PAGI-SYM and PAGI-QOL among healing and maintenance of erosive esophagitis clinical trial participants.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2010;19(4):551-64.
2010: Margaret K Vernon; Dennis A Revicki; A George Awad; Riad Dirani; Jessica Panish; Carla M Canuso; Augusto Grinspan; Sally Mannix; Amir H Kalali
Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients.
Schizophrenia research 2010;118(1-3):271-8.
2010: Kirsten L Johansen; Fredric O Finkelstein; Dennis A Revicki; Matthew Gitlin; Christopher P Evans; Tracy J Mayne
Systematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2010;55(3):535-48.
2010: Gahan J Pandina; Georges M Garibaldi; Dennis A Revicki; Leah Kleinman; Ibrahim Turkoz; Mary Kujawa; Ramy A Mahmoud
Psychometric evaluation of a Patient-Rated Most Troubling Symptom Scale for Depression: findings from a secondary analysis of a clinical trial.
International clinical psychopharmacology 2010;25(2):51-9.
2010: Donald E Stull; Margaret K Vernon; Jason C Legg; Hema N Viswanathan; Diane Fairclough; Dennis A Revicki
Use of latent growth curve models for assessing the effects of darbepoetin alfa on hemoglobin and fatigue.
Contemporary clinical trials 2010;31(2):172-9.
2010: Dennis A Revicki; Anne M Rentz; Neesha Harnam; Vince THOMAS; Paolo Lanzetta
Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
Investigative ophthalmology & visual science 2010;51(2):712-7.
2010: Murali Sundaram; Michael J Smith; Dennis A Revicki; Lesley-Ann Miller; Suresh Madhavan; Gerry Hobbs
Estimation of a valuation function for a diabetes mellitus-specific preference-based measure of health: the Diabetes Utility Index.
PharmacoEconomics 2010;28(3):201-16.
2009: Dennis A Revicki; Carolyn E Schwartz
Intellectual property rights and good research practice.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(10):1279-80.
2009: Kitty S Chan; Wen-Hung Chen; T J Gan; RH Hsieh; Connie Chen; Mani Lakshminarayanan; Dennis A Revicki
Development and validation of a composite score based on clinically meaningful events for the opioid-related symptom distress scale.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(10):1331-40.
2009: Kathleen Wyrwich; Neesha Harnam; Dennis A Revicki; Julie C Locklear; Henrik Svedsäter; Jean Endicott
Assessing health-related quality of life in generalized anxiety disorder using the Quality Of Life Enjoyment and Satisfaction Questionnaire.
International clinical psychopharmacology 2009;24(6):289-95.
2009: Dennis A Revicki; Wen-Hung Chen; Neesha Harnam; Karon F Cook; Dagmar Amtmann; Leigh F Callahan; Mark P Jensen; Francis J Keefe
Development and psychometric analysis of the PROMIS pain behavior item bank.
Pain 2009;146(1-2):158-69.
2009: Gahan J Pandina; Dennis A Revicki; Leah Kleinman; Ibrahim Turkoz; Jasmanda H Wu; Mary J Kujawa; Ramy Mahmoud; Georges Gharabawi
Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
Journal of affective disorders 2009;118(1-3):139-46.
2009: Wen-Hung Chen; Dennis A Revicki; Jin-Shei Lai; Karon F Cook; Dagmar Amtmann
Linking pain items from two studies onto a common scale using item response theory.
Journal of pain and symptom management 2009;38(4):615-28.
2009: Dennis A Revicki; M Camilleri; B Kuo; N J Norton; L Murray; A Palsgrove; H P Parkman
Development and content validity of a gastroparesis cardinal symptom index daily diary.
Alimentary pharmacology & therapeutics 2009;30(6):670-80.
2009: Ron D Hays; Jakob B Bjorner; Dennis A Revicki; Karen L Spritzer; David Cella
Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(7):873-80.
2009: Murali Sundaram; Michael J Smith; Dennis A Revicki; Betsy Elswick; Lesley-Ann Miller
Rasch analysis informed the development of a classification system for a diabetes-specific preference-based measure of health.
Journal of clinical epidemiology 2009;62(8):845-56.
2009: Dennis A Revicki; Ariane K Kawata; Neesha Harnam; Wen-Hung Chen; Ron D Hays; David Cella
Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(6):783-91.
2009: I-Chan Huang; Lindsay A Thompson; Yueh-Yun Chi; Caprice A Knapp; Dennis A Revicki; Michael Seid; Elizabeth A Shenkman
The linkage between pediatric quality of life and health conditions: establishing clinically meaningful cutoff scores for the PedsQL.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(5):773-81.
2009: Robert H Dworkin; Dennis C Turk; Dennis A Revicki; Gale Harding; Karin S Coyne; Sarah Peirce-Sandner; Dileep Bhagwat; Dennis Everton; Laurie B Burke; Penney Cowan; John T Farrar; Sharon Hertz; Mitchell B Max; Bob A Rappaport; Ronald Melzack
Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2).
Pain 2009;144(1-2):35-42.
2009: Stephen Joel Coons; Chad J Gwaltney; Ron D Hays; J Jason Lundy; Jeff A Sloan; Dennis A Revicki; William R Lenderking; David Cella; Ethan Basch
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(4):419-29.
2009: I-Chan Huang; Elizabeth A Shenkman; Walter Leite; Caprice A Knapp; Lindsay A Thompson; Dennis A Revicki
Agreement was not found in adolescents' quality of life rated by parents and adolescents.
Journal of clinical epidemiology 2009;62(3):337-46.
2009: Leah Kleinman; Jeffrey Lieberman; Sanjay Dube; Richard C Mohs; Yang Zhao; Bruce Kinon; William T Carpenter; Philip D Harvey; Michael F Green; Richard S E Keefe; Lori Frank; Lee Bowman; Dennis A Revicki
Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function.
Schizophrenia research 2009;107(2-3):275-85.
2009: John J Vargo; Kellee Howard; Jennifer Petrillo; Judith Scott; Dennis A Revicki
Development and validation of the patient and clinician sedation satisfaction index for colonoscopy and upper endoscopy.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(2):156-62.
2009: Robin F Pokrzywinski; David M Meads; Stephen P McKenna; G Alistair Glendenning; Dennis A Revicki
Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS).
Health and quality of life outcomes 2009;7():98.
2009: Désirée M van der Heijde; Dennis A Revicki; Katherine L Gooch; Robert L Wong; Hartmut Kupper; Neesha Harnam; Chris Thompson; Joachim Sieper
Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis.
Arthritis research & therapy 2009;11(4):R124.
2009: Richard M Langford; Girish P Joshi; Tong J Gan; Maria Stoeckl Mattera; Wen-Hung Chen; Dennis A Revicki; Connie Chen; Gergana Zlateva
Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial.
Clinical drug investigation 2009;29(9):577-90.
2009: Ariane K Kawata; Dennis A Revicki; Roopal Thakkar; Ping Jiang; Scott Krause; Michael H Davidson; Henry A Punzi; Robert J Padley
Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy.
Clinical drug investigation 2009;29(4):215-29.
2009: Dennis A Revicki; Anne M Rentz; Michelle P Luo; Robert L Wong; Lynda C Doward; Stephen P McKenna
Psychometric characteristics of the ankylosing spondylitis quality of life questionnaire, short form 36 health survey, and functional assessment of chronic illness therapy-fatigue subscale.
Health and quality of life outcomes 2009;7():6.
2008: Dennis A Revicki; Nancy Brandenburg; Louis Matza; Mark C. Hornbrook; David Feeny
Health-related quality of life and utilities in primary-care patients with generalized anxiety disorder.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2008;17(10):1285-94.
2008: Ariane K Kawata; Dennis A Revicki
Psychometric properties of the Personal and Social Performance scale (PSP) among individuals with schizophrenia living in the community.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2008;17(10):1247-56.
2008: Dennis C Turk; Robert H Dworkin; Michael P McDermott; Nicholas Bellamy; Laurie B Burke; Julie M Chandler; Charles S Cleeland; Penney Cowan; Rozalina Dimitrova; John T Farrar; Sharon Hertz; Joseph F Heyse; Smriti Iyengar; Alejandro R Jadad; Gary W Jay; John A Jermano; Nathaniel P Katz; Donald C Manning; Susan Martin; Mitchell B Max; Patrick McGrath; Henry J McQuay; Steve Quessy; Bob A Rappaport; Dennis A Revicki; Margaret Rothman; JOSEPH STAUFFER; Ola Svensson; Richard E White; James Witter
Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials.
Pain 2008;139(3):485-93.
2008: Dennis A Revicki; Michelle P Luo; Paul Wordsworth; Robert L Wong; Naijun Chen; John C Davis
Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).
The Journal of rheumatology 2008;35(7):1346-53.
2008: Margaret K Vernon; Nancy Brandenburg; Jose Ma J Alvir; Teresa Griesing; Dennis A Revicki
Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients.
Journal of pain and symptom management 2008;36(1):54-68.
2008: M Kimel; R Hsieh; J McCormack; S P Burch; Dennis A Revicki
Validation of the revised Patient Perception of Migraine Questionnaire (PPMQ-R): measuring satisfaction with acute migraine treatment in clinical trials.
Cephalalgia : an international journal of headache 2008;28(5):510-23.
2008: José M Valderas; A Kotzeva; Mireia Espallargues; G Guyatt; Carol J Ferrans; Michele Y Halyard; Dennis A Revicki; T Symonds; A Parada; Jordi Alonso
The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2008;17(2):179-93.
2008: Ariane K Kawata; Dennis A Revicki
Reliability and validity of the social integration survey (SIS) in patients with schizophrenia.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2008;17(1):123-35.
2008: Dennis A Revicki; Alan Menter; Steven Feldman; Miriam Kimel; Neesha Harnam; Mary Kaye Willian
Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.
Health and quality of life outcomes 2008;6():75.
2008: Gahan J Pandina; Dennis A Revicki; Leah Kleinman; Ibrahim Turkoz; Jasmanda Wu; Ramy Mahmoud; Georges Gharabawi
Psychometric evaluation of a patient-rated troubling symptom scale for generalized anxiety disorder clinical trials.
Psychopharmacology bulletin 2008;41(3):68-90.
2008: Dennis A Revicki; Mary Kaye Willian; Alan Menter; Jean-Hilaire Saurat; Neesha Harnam; Martin Kaul
Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
Dermatology (Basel, Switzerland) 2008;216(3):260-70.
2008: Philip J Mease; Dennis A Revicki; Jacek Szechinski; Maria Greenwald; Alan J Kivitz; Leonor Barile-Fabris; Jatinderpal Kalsi; Jennifer Eames; Marjatta Leirisalo-Repo
Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
The Journal of rheumatology 2008;35(1):20-30.
2007: Joseph Lipscomb Jr; Bryce B Reeve; Steven B Clauser; Jeffrey S Abrams; Deborah Watkins-Bruner; Laurie B Burke; Andrea M Denicoff; Patricia Anne Ganz; Kathleen Gondek; Lori M Minasian; Ann M O'Mara; Dennis A Revicki; Edwin P Rock; Julia H Rowland; Maria Sgambati; Edward L Trimble
Patient-reported outcomes assessment in cancer trials: taking stock, moving forward.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(32):5133-40.
2007: Dennis A Revicki; Pennifer A Erickson; Jeff A Sloan; Amylou Dueck; Harry A Guess; Nancy C Santanello
Interpreting and reporting results based on patient-reported outcomes.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10 Suppl 2():S116-24.
2007: Jeff A Sloan; Amylou Dueck; Pennifer A Erickson; Harry A Guess; Dennis A Revicki; Nancy C Santanello
Analysis and interpretation of results based on patient-reported outcomes.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10 Suppl 2():S106-15.
2007: Gordon H Guyatt; Carol J Ferrans; Michele Y Halyard; Dennis A Revicki; Tara L Symonds; Claudette G Varricchio; Anna Kotzeva; Jose M Valderas; Jordi Alonso; Jordi L Alonso
Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice.
Mayo Clinic proceedings. Mayo Clinic 2007;82(10):1229-39.
2007: Graeme Russ; Neville Jamieson; Rainer Oberbauer; Manuel Arias; Maria G Murgia; Gilles Blancho; Reiko Sato; Maria Stoeckl; Dennis A Revicki
Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine.
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(10):875-83.
2007: Lori Frank; Louis S Matza; Jennifer Hanlon; Sally Mannix; Dennis A Revicki; Douglas E Feltner; Robert J Morlock
The patient experience of depression and remission: focus group results.
The Journal of nervous and mental disease 2007;195(8):647-54.
2007: Bryce B Reeve; Ron Hays; Jakob B Bjorner; Karon F Cook; Paul K Crane; Jeanne A Teresi; David Thissen; Dennis A Revicki; David J Weiss; Ronald K Hambleton; Honghu Liu; Richard Gershon; Steven P Reise; Jin-Shei Lai; David Cella
Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).
Medical care 2007;45(5 Suppl 1):S22-31.
2007: Dennis A Revicki; Ari Gnanasakthy; Kevin P Weinfurt
Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(4):717-23.
2007: Dennis A Revicki
FDA draft guidance and health-outcomes research.
Lancet 2007;369(9561):540-2.
2007: Dennis A Revicki; Mary Kaye Willian; Alan Menter; Kenneth B Gordon; Alexa B Kimball; Craig L Leonardi; Richard G B Langley; Miriam Kimel; Martin Okun
Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.
The Journal of dermatological treatment 2007;18(6):341-50.
2007: Gale Harding; David Cella; Don Robinson; Parthiv Mahadevia; Jason Clark; Dennis A Revicki
Symptom burden among patients with renal cell carcinoma (RCC): content for a symptom index.
Health and quality of life outcomes 2007;5():34.
2007: Dennis A Revicki; Jeff Sloan
Practical and philosophical issues surrounding a national item bank: if we build it will they come?
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16 Suppl 1():167-74.
2007: Richard Shikiar; Michael Heffernan; Richard G B Langley; Mary Kaye Willian; Martin M Okun; Dennis A Revicki
Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial.
The Journal of dermatological treatment 2007;18(1):25-31.
2006: Louis S Matza; Robert W Buchanan; Scot Purdon; Jessica Brewster-Jordan; Yang Zhao; Dennis A Revicki
Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment.
Schizophrenia bulletin 2006;32(4):666-78.
2006: Dennis A Revicki
National health preference data: a useful resource for health services research.
Medical decision making : an international journal of the Society for Medical Decision Making 2006;26(4):310-2.
2006: Leah Kleinman; Dennis A Revicki; Emuella Flood
Validation issues in questionnaires for diagnosis and monitoring of gastroesophageal reflux disease in children.
Current gastroenterology reports 2006;8(3):230-6.
2006: Phoebe S Y Lo; Michael C F Tong; Dennis A Revicki; Ching Chyi Lee; John K S Woo; Henry Chuen Kwong Lam; C Andrew van Hasselt
Rhinitis Symptom Utility Index (RSUI) in Chinese subjects: a multiattribute patient-preference approach.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(5):877-87.
2006: Leah Kleinman; Margaret Rothman; Richard Strauss; Susan R Orenstein; Suzanne Nelson; Yvan Vandenplas; Salvatore Cucchiara; Dennis A Revicki
The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(5):588-96.
2006: Dennis A Revicki; David Feeny; Timothy L Hunt; Bernard F Cole
Analyzing oncology clinical trial data using the Q-TWiST method: clinical importance and sources for health state preference data.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(3):411-23.
2006: Kimberly Niebauer; Sarah Dewilde; Julia Fox-Rushby; Dennis A Revicki
Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2006;96(2):316-26.
2006: Dennis A Revicki; Miriam Kimel; Kathleen M Beusterien; Jackie W Kwong; Julie A Varner; Michael H Ames; Sunny Mahajan; Roger K Cady
Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment.
Headache 2006;46(2):240-52.
2006: Richard Shikiar; Mary Kaye Willian; Martin M Okun; Christine S Thompson; Dennis A Revicki
The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
Health and quality of life outcomes 2006;4():71.
2006: Dennis A Revicki; David Cella; Ron Hays; Jeff A Sloan; William R Lenderking; Neil K Aaronson
Responsiveness and minimal important differences for patient reported outcomes.
Health and quality of life outcomes 2006;4():70.
2006: Emuella Flood; Erwin De Cock; Ann-Christin Mörk; Dennis A Revicki
Evaluating preference weights for the Asthma Symptom Utility Index (ASUI) across countries.
Health and quality of life outcomes 2006;4():51.
2006: Rachael Fleurence; Julia M Dixon; Dennis A Revicki
Economics of atypical antipsychotics in bipolar disorder: a review of the literature.
CNS drugs 2006;20(7):591-9.
2005: Dennis A Revicki; Clark Paramore; Anne M Rentz
Incorporating pharmacoeconomic and health outcomes into randomized clinical trials.
Expert review of pharmacoeconomics & outcomes research 2005;5(6):695-703.
2005: Lori B Frank; Louis S Matza; Dennis A Revicki; Joyce Y Chung
Depression and health-related quality of life for low-income African-American women in the U.S.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2005;14(10):2293-301.
2005: Kevin B Weiss; L Clark Paramore; Bengt Liljas; Dennis A Revicki; Bryan R Luce
Patient satisfaction with budesonide Turbuhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler in a managed care setting.
The Journal of asthma : official journal of the Association for the Care of Asthma 2005;42(9):769-76.
2005: Dennis A Revicki; Juned Siddique; Lori Frank; Joyce Y Chung; Bonnie L Green; Janice Krupnick; Manishi Prasad; Jeanne Miranda
Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women.
Archives of general psychiatry 2005;62(8):868-75.
2005: Dennis A Revicki; Jennifer Hanlon; Silas Martin; Laszlo Gyulai; S Nassir Ghaemi; Frances L. Lynch; Sally Mannix; Leah Kleinman
Patient-based utilities for bipolar disorder-related health states.
Journal of affective disorders 2005;87(2-3):203-10.
2005: Dennis A Revicki
Methodological issues and the measurement of fatigue in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2005;42(1):24-6.
2005: Michael Camilleri; Dominique Dubois; Bernard Coulie; Michael Jones; Peter J Kahrilas; Anne M Rentz; Amnon Sonnenberg; Vincenzo Stanghellini; Walter F Stewart; Jan Tack; Nicholas J Talley; William E Whitehead; Dennis A Revicki
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(6):543-52.
2005: Dennis A Revicki; Robert M A Hirschfeld; Eileen P Ahearn; Richard H Weisler; Cynthia Palmer; Paul E Keck
Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Journal of affective disorders 2005;86(2-3):183-93.
2005: Amy E Bonomi; Denise M Boudreau; Paul A Fishman; Richard T. Meenan; Dennis A Revicki
Is a family equal to the sum of its parts? Estimating family-level well-being for cost-effectiveness analysis.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2005;14(4):1127-33.
2005: Louis S Matza; Kristina Secnik; Anne M Rentz; Sally Mannix; Floyd R Sallee; Donald Gilbert; Dennis A Revicki
Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2005;14(3):735-47.
2005: Anne M Rentz; Louis S Matza; Kristina Secnik; Andrine R Swensen; Dennis A Revicki
Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2005;14(3):719-34.
2005: Louis S Matza; Timothy Baker; Dennis A Revicki
Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review.
CNS drugs 2005;19(6):499-515.
2005: Dennis A Revicki; Louis S Matza; Emuella Flood; Andrew Lloyd
Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials.
PharmacoEconomics 2005;23(6):583-94.
2005: Elaine McColl; Ola Junghard; Ingela Wiklund; Dennis A Revicki
Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?
The American journal of gastroenterology 2005;100(1):11-8.
2004: Christine de la Loge; Elyse Trudeau; Patrick Marquis; Peter J Kahrilas; Vincenzo Stanghellini; Nicholas J Talley; Jan Tack; Dennis A Revicki; Anne M Rentz; Dominique Dubois
Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(10):1751-62.
2004: Anne M Rentz; Peter J Kahrilas; Vincenzo Stanghellini; Jan Tack; Nicholas J Talley; Christine de la Loge; Elyse Trudeau; Dominique Dubois; Dennis A Revicki
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(10):1737-49.
2004: Christine de la Loge; Elyse Trudeau; Patrick Marquis; Dennis A Revicki; Anne M Rentz; Vincenzo Stanghellini; Nicholas J Talley; Peter J Kahrilas; Jan Tack; Dominique Dubois
Responsiveness and interpretation of a quality of life questionnaire specific to upper gastrointestinal disorders.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(9):778-86.
2004: Dennis A Revicki; Anne M Rentz; Jan Tack; Vincenzo Stanghellini; Nicholas J Talley; Peter J Kahrilas; Christine de la Loge; Elyse Trudeau; Dominique Dubois
Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(9):769-77.
2004: Karin S Coyne; Mary Kay Margolis; Tessa Kennedy-Martin; Timothy Baker; Ronald Klein; Matthew D Paul; Dennis A Revicki
The impact of diabetic retinopathy: perspectives from patient focus groups.
Family practice 2004;21(4):447-53.
2004: Karin S Coyne; Chris Payne; Samir K Bhattacharyya; Dennis A Revicki; Christine Thompson; Ron Corey; Timothy L Hunt
The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2004;7(4):455-63.
2004: Louis S Matza; Anne M Rentz; Kristina Secnik; Andrine R Swensen; Dennis A Revicki; David Michelson; Thomas Spencer; Jeffrey H Newcorn; Christopher J Kratochvil
The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder.
Journal of developmental and behavioral pediatrics : JDBP 2004;25(3):166-74.
2004: Dennis A Revicki; Anne M Rentz; Dominique Dubois; Peter J Kahrilas; Vincenzo Stanghellini; Nicholas J Talley; Jan Tack
Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(4):833-44.
2004: Dennis A Revicki
Cost-effectiveness and HRQOL outcomes of divalproex sodium (Depakote) in bipolar disorder.
Expert review of pharmacoeconomics & outcomes research 2004;4(1):9-14.
2003: Louis S Matza; Dennis A Revicki; Jonathan R Davidson; Jonathan W Stewart
Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences.
Archives of general psychiatry 2003;60(8):817-26.
2003: Karin S Coyne; Mary Kay Margolis; Kim A Gilchrist; Susan Grandy; William R Hiatt; Andrea Ratchford; Dennis A Revicki; William S Weintraub; Judith G Regensteiner
Evaluating effects of method of administration on Walking Impairment Questionnaire.
Journal of vascular surgery 2003;38(2):296-304.
2003: Jeanne Miranda; Joyce Y Chung; Bonnie L Green; Janice Krupnick; Juned Siddique; Dennis A Revicki; Thomas R Belin
Treating depression in predominantly low-income young minority women: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2003;290(1):57-65.
2003: Dennis A Revicki; Anne M Rentz; Dominique Dubois; Peter J Kahrilas; Vincenzo Stanghellini; Nicholas J Talley; Jan Tack
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.
Alimentary pharmacology & therapeutics 2003;18(1):141-50.
2003: Rainer Oberbauer; Brian Hutchison; Josette Eris; Manuel Arias; Kerstin Claesson; Alfredo Mota; Henri Kreis; Leah Kleinman; F Wang; J Chen; Dennis A Revicki
Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial.
Transplantation 2003;75(8):1277-85.
2003: Dennis A Revicki; L Clark Paramore; Kenneth W Sommerville; Alan C Swann; John M Zajecka
Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.
The Journal of clinical psychiatry 2003;64(3):288-94.
2003: Dennis A Revicki; Marc W Zodet; Sandra Joshua-Gotlib; Douglas Levine; Joseph A Crawley
Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity.
Health and quality of life outcomes 2003;1():73.
2003: Richard Shikiar; Brian W Bresnahan; Stephen P Stone; Christine Thompson; John Koo; Dennis A Revicki
Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials.
Health and quality of life outcomes 2003;1():53.
2003: Manishi Prasad; Anne M Rentz; Dennis A Revicki
The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review.
PharmacoEconomics 2003;21(11):769-90.
2003: Jens Rasenack; Stefan Zeuzem; S Victor Feinman; E Jenny Heathcote; Michael Manns; Eric M Yoshida; Mark G Swain; Edward Gane; Moisés Diago; Dennis A Revicki; Amy Lin; Neil Wintfeld; Jesse Green
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C.
PharmacoEconomics 2003;21(5):341-9.
2002: Cynthia S Palmer; Elizabeth Brunner; Luis Guillermo Ruíz-Flores; Francisco Paez-Agraz; Dennis A Revicki
A cost-effectiveness clinical decision analysis model for treatment of Schizophrenia.
Archives of medical research 2002;33(6):572-80.
2002: Carol E Koro; Donald O. Fedder; Gilbert J L'Italien; Sheila Weiss Smith; Laurence S Magder; Julie Kreyenbuhl; Dennis A Revicki; Robert W Buchanan
Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.
BMJ (Clinical research ed.) 2002;325(7358):243.
2002: Dennis A Revicki
Consistent patient-reported outcomes.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2002;5(4):295-6.
2002: Mirjam A G Sprangers; Carol M Moinpour; Timothy J Moynihan; Donald L Patrick; Dennis A Revicki
Assessing meaningful change in quality of life over time: a users' guide for clinicians.
Mayo Clinic proceedings. Mayo Clinic 2002;77(6):561-71.
2002: Maria K L Eng; Albert W Wu; Dennis A Revicki
Incorporating quality of life measures in HIV clinical trials.
HIV clinical trials 2002;3(3):202-18.
2002: David Bernstein; Leah Kleinman; Chris M Barker; Dennis A Revicki; Jesse Green
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients.
Hepatology (Baltimore, Md.) 2002;35(3):704-8.
2002: Mary Kay Margolis; Karin S Coyne; Tessa Kennedy-Martin; Timothy Baker; Oliver D Schein; Dennis A Revicki
Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review.
PharmacoEconomics 2002;20(12):791-812.
2001: Dennis A Revicki
Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence.
Current opinion in investigational drugs (London, England : 2000) 2001;2(1):110-7.
2001: Anne M Rentz; C Battista; Elyse Trudeau; R Jones; P Robinson; S Sloan; S Mathur; Lori Frank; Dennis A Revicki
Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature.
PharmacoEconomics 2001;19(4):349-63.
2001: Dennis A Revicki; K Gold; D Buckman; Kitty S Chan; Joel Kallich; J M Woolley
Imputing physical health status scores missing owing to mortality: results of a simulation comparing multiple techniques.
Medical care 2001;39(1):61-71.
2000: Susan H Hamilton; Eric T Edgell; Dennis A Revicki; Alan Breier
Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample.
International clinical psychopharmacology 2000;15(5):245-55.
2000: B Kaplan-Machlis; G E Spiegler; MW Zodet; Dennis A Revicki
Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia.
Archives of family medicine 2000;9(7):624-30.
1999: Dennis A Revicki; J A Crawley; MW Zodet; D S Levine; B O Joelsson
Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease.
Alimentary pharmacology & therapeutics 1999;13(12):1621-30.
1999: Dennis A Revicki; LA Genduso; Susan H Hamilton; D Ganoczy; Charles Beasley
Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1999;8(5):417-26.
1999: Susan H Hamilton; Dennis A Revicki; Eric T Edgell; LA Genduso; Gary D Tollefson
Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial.
PharmacoEconomics 1999;15(5):469-80.
1999: Dennis A Revicki; Lori Frank
Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies.
PharmacoEconomics 1999;15(5):423-34.
1999: Nancy Kline Leidy; Dennis A Revicki; B Genesté
Recommendations for evaluating the validity of quality of life claims for labeling and promotion.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 1999;2(2):113-27.
1999: Dennis A Revicki
Pharmacoeconomic evaluation of treatments for refractory schizophrenia: clozapine-related studies.
The Journal of clinical psychiatry 1999;60 Suppl 1():7-11; discussion 28-30.
1999: Dennis A Revicki; K R Yabroff; Richard Shikiar
Outcomes research in radiologic imaging: identification of barriers and potential solutions.
Academic radiology 1999;6 Suppl 1():S20-8.
1998: Dennis A Revicki; N K Leidy; F Brennan-Diemer; C Thompson; A Togias
Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1998;7(8):693-702.
1998: Dennis A Revicki; Gregory E Simon; Kitty S Chan; Wayne Katon; J Heiligenstein
Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
The Journal of family practice 1998;47(6):446-52.
1998: Dennis A Revicki; N K Leidy; F Brennan-Diemer; S Sorensen; A Togias
Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index.
Chest 1998;114(4):998-1007.
1998: Dennis A Revicki; S Sorensen; P N Maton; Roy C Orlando
Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease.
Digestive diseases (Basel, Switzerland) 1998;16(5):284-91.
1998: Cynthia S Palmer; Dennis A Revicki; LA Genduso; Susan H Hamilton; R E Brown
A cost-effectiveness clinical decision analysis model for schizophrenia.
The American journal of managed care 1998;4(3):345-55.
1998: Dennis A Revicki; M Wood; P N Maton; S Sorensen
The impact of gastroesophageal reflux disease on health-related quality of life.
The American journal of medicine 1998;104(3):252-8.
1998: N K Leidy; C Palmer; M Murray; J Robb; Dennis A Revicki
Health-related quality of life assessment in euthymic and depressed patients with bipolar disorder. Psychometric performance of four self-report measures.
Journal of affective disorders 1998;48(2-3):207-14.
1998: Dennis A Revicki; M Wood
Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications.
Journal of affective disorders 1998;48(1):25-36.
1998: Dennis A Revicki; S Sorensen; Albert W Wu
Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey.
Medical care 1998;36(2):126-37.
1998: Dennis A Revicki; M Wood; I Wiklund; J Crawley
Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1998;7(1):75-83.
1998: Barbara Bartman; M J Rosen; Douglas D Bradham; J Weissman; Marc C Hochberg; Dennis A Revicki
Relationship between health status and utility measures in older claudicants.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1998;7(1):67-73.
1998: Susan H Hamilton; Dennis A Revicki; LA Genduso; Charles Beasley
Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;18(1):41-9.
1997: Dennis A Revicki; David Cella
Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1997;6(6):595-600.
1997: Dennis A Revicki; C S Palmer; S D Phillips; J A Reblando; J H Heiligenstein; Jeffrey Brent; K Kulig
Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicentre study of antidepressant drug overdoses.
PharmacoEconomics 1997;11(1):48-55.
1996: Gregory E Simon; Michael VonKorff; J H Heiligenstein; Dennis A Revicki; Louis Grothaus; Wayne Katon; E H Wagner
Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants.
JAMA : the journal of the American Medical Association 1996;275(24):1897-902.
1994: Dennis A Revicki; D Irwin; J Reblando; G E Simon
The accuracy of self-reported disability days.
Medical care 1994;32(4):401-4.
1994: E J Hatziandreu; R E Brown; Dennis A Revicki; R Turner; J Martindale; S Levine; J E Siegel
Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin.
PharmacoEconomics 1994;5(3):249-68.
1993: Dennis A Revicki; R M Kaplan
Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1993;2(6):477-87.
1993: M L Rothman; Dennis A Revicki
Issues in the measurement of health status in asthma research.
Medical care 1993;31(3 Suppl):MS82-96.
1992: Dennis A Revicki; R Turner; R Brown; J J Martindale
Reliability and validity of a health-related quality of life battery for evaluating outpatient antidepressant treatment.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1992;1(4):257-66.
1992: Dennis A Revicki
Relationship between health utility and psychometric health status measures.
Medical care 1992;30(5 Suppl):MS274-82.